Theseus Pharmaceuticals Inc (THRX) Peer Comparison

$4.06

$0.00 (0.00%)

As on 23-Feb-2024 09:30EDT

Market cap

$181 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.8

Div. Yield

0 %

Edit

	Theseus Pharmaceuticals Inc (THRX)	Freeline TherapeuticsÂ Holdings Plc (FRLN)
Market cap ($ Mln)	181	28
Revenue ($ Mln)	--	1
Net Profit ($ Mln)	-55.86	-74.10
Net Margin (%)	-778.31	-11,912.70
RoE (%)	-23.77	-179.73
Price to Earnings	--	--
Price-To-Book	0.81	0.95

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Theseus Pharmaceuticals Inc (THRX)	Freeline TherapeuticsÂ Holdings Plc (FRLN)
Operating Revenue	0.00	0.62
Cost of Revenue	0.49	1.14
Gross Profit	-0.44	-1.74
Operating Expenses	66.52	66.19
Operating Profit (EBIT)	-66.52	-67.67
Other Income	7.18	0.00
Profit before Tax	-56.61	-73.51
Provision for Tax	-0.78	0.59
Profit after Tax (Net Income)	-55.86	-74.10
Minority Interest	0.00	0.00
Consolidated Profit	-43.11	-37.84

Liabilities ($ Mln)

	Theseus Pharmaceuticals Inc (THRX)	Freeline TherapeuticsÂ Holdings Plc (FRLN)
Shareholder's Funds	224.52	30.04
Minority Interest	0.00	0.00
Non-Current Liabilities	3.10	1.70
Current Liabilities	7.00	17.48
Total Liabilities	222.45	86.64

Assets ($ Mln)

	Theseus Pharmaceuticals Inc (THRX)	Freeline TherapeuticsÂ Holdings Plc (FRLN)
Non-Current Assets	25.04	15.22
Current Assets	209.59	34.00
Total Assets	222.45	86.64
Total Debt*	3.66	3.99
Net Current Assets	202.58	16.52

Cashflow ($ Mln)

	Theseus Pharmaceuticals Inc (THRX)	Freeline TherapeuticsÂ Holdings Plc (FRLN)
Cash From Operating Activities	-32.95	-78.22
Cash Flow from Investing Activities	-117.29	--
Cash from Financing Activities	0.18	27.52
Net Cash Inflow / Outflow	-150.06	--

Ratios

Profitability Ratios

	Theseus Pharmaceuticals Inc (THRX)	Freeline TherapeuticsÂ Holdings Plc (FRLN)
ROCE (%)	-20.56	-99.53
ROE (%)	-23.77	-179.73
ROA (%)	-23.29	-78.33
EBIT Margin (%)	--	-11,456.11
Net Margin (%)	-778.31	-11,912.70
Cash Profit Margin (%)	--	-0.01

Growth Ratios

	Theseus Pharmaceuticals Inc (THRX)	Freeline TherapeuticsÂ Holdings Plc (FRLN)
Revenue Growth (%)	--	--
EBIT Growth (%)	-40.88	35.21
Net Profit Growth (%)	-27.44	26.40
EPS Growth (%)	-15.13	--
Book Value Growth (%)	-9.52	--

Valuation Ratios

	Theseus Pharmaceuticals Inc (THRX)	Freeline TherapeuticsÂ Holdings Plc (FRLN)
Price / Earnings	-4.09	--
Price / Book Value	0.93	--
Dividend Yield (%)	--	--
EV/EBITDA	0.02	0.43
Market Cap ($ Cr)	--	--

Solvency Ratios

	Theseus Pharmaceuticals Inc (THRX)	Freeline TherapeuticsÂ Holdings Plc (FRLN)
Debt to Equity	0.00	0.00
Short term debt to equity ratio	0.00	0.08
Current Ratio	29.93	1.95
Quick Ratio	29.93	1.90
Interest Coverage	-12.53	-4.76

Operating Efficiency Ratios

	Theseus Pharmaceuticals Inc (THRX)	Freeline TherapeuticsÂ Holdings Plc (FRLN)
Debtors to sales (%)	--	453.86
Asset Turnover	0.00	0.01
Receivable days	--	1,018.50
Inventory Days	--	2,525.58
Payable days	2,491.29	1,600.14
Cash Conversion Cycle	--	1,943.94

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly